Pentasa Granules 94% from Kyorin Pharmaceutical (YJ code: 2399009D2020, 94%1g) contain mesalazine, an aminosalicylate used to treat inflammatory bowel disease (IBD). It is effective for mild to moderately active ulcerative colitis and Crohn’s disease, and for maintaining remission by reducing intestinal inflammation.
Pentasa Granules 94%
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
